Drug
Escitalopram 20 mg
Escitalopram 20 mg is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Phase Distribution
Ph phase_1
2
40%
Ph phase_2
1
20%
Ph phase_4
2
40%
Phase Distribution
2
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 4Post-market surveillance
2(40.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
80.0%
4 of 5 finished
Non-Completion Rate
20.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(4)
Terminated(1)
Detailed Status
Completed4
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 12 (40.0%)
Phase 21 (20.0%)
Phase 42 (40.0%)
Trials by Status
completed480%
withdrawn120%
Recent Activity
0 active trials
Showing 5 of 5
withdrawnphase_1
The DPP-4 Inhibitor Vildagliptin as Adjunct in Major Depressive Disorder Patients
NCT04410341
completedphase_1
A Study to Assess Serotonin Transporter Occupancy of Healthy Adults Using 11C-DASB PET
NCT06476509
completedphase_4
Serotonergic Modulation of Cognition, Emotion and Brain Activation in Healthy Volunteers
NCT04239339
completedphase_4
The Effect of Escitalopram in PCOS
NCT05840692
completedphase_2
Short-term Study of Combination Treatment of Escitalopram and Gaboxadol in Major Depressive Disorder
NCT00807248
Clinical Trials (5)
Showing 5 of 5 trials
NCT04410341Phase 1
The DPP-4 Inhibitor Vildagliptin as Adjunct in Major Depressive Disorder Patients
NCT06476509Phase 1
A Study to Assess Serotonin Transporter Occupancy of Healthy Adults Using 11C-DASB PET
NCT04239339Phase 4
Serotonergic Modulation of Cognition, Emotion and Brain Activation in Healthy Volunteers
NCT05840692Phase 4
The Effect of Escitalopram in PCOS
NCT00807248Phase 2
Short-term Study of Combination Treatment of Escitalopram and Gaboxadol in Major Depressive Disorder
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5